Thalassemia is a genetic disorder that affects the production of hemoglobin, a protein found in red blood cells that carries oxygen throughout the body. It is caused by mutations in the genes that control the production of hemoglobin, which leads to the production of abnormal hemoglobin molecules or a decrease in the amount of hemoglobin produced.
There are two main types of thalassemia: alpha thalassemia and beta thalassemia. Alpha thalassemia occurs when there is a defect in the genes that produce alpha globin chains, while beta thalassemia occurs when there is a defect in the genes that produce beta globin chains.
Epidemiology
Thalassemia is a global health problem, with an estimated 300,000 to 500,000 babies born with the disorder each year worldwide. The prevalence of thalassemia varies widely depending on the region and ethnic group. The disorder is most common in populations from the Mediterranean, Middle East, South Asia, and Southeast Asia, where it is estimated that up to 8% of the population may carry the genetic mutation for thalassemia.
In these regions, thalassemia is often referred to as a “silent epidemic.” In the United States, thalassemia is relatively rare, with an estimated 1,000 cases diagnosed each year. It is most commonly found in people of Italian, Greek, Middle Eastern, and Asian descent. Thalassemia is more prevalent in areas where malaria is endemic, as carriers of the thalassemia gene are less likely to develop severe forms of the disease.
As a result, the highest rates of thalassemia occur in areas where malaria is prevalent, such as in sub-Saharan Africa, Southeast Asia, and parts of the Middle East. Overall, thalassemia is a significant public health issue with a substantial impact on affected individuals and their families. It is important for healthcare providers to be aware of the prevalence of thalassemia in their patient populations and to provide appropriate screening and management of the disorder.
Anatomy
Pathophysiology
Etiology
There are two types of thalassemia: alpha thalassemia and beta thalassemia. Alpha thalassemia occurs when there is a mutation in one or more of the four genes that control the production of alpha globin chains. Beta thalassemia occurs when there is a mutation in one or both of the two genes that control the production of beta-globin chains.
In most cases, thalassemia is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. People who inherit only one copy of the mutated gene are carriers of the disorder and typically do not experience any symptoms.
There are also rare cases of thalassemia that are caused by spontaneous mutations in the genes responsible for the production of hemoglobin. These cases are not inherited and occur randomly in individuals with no family history of the disorder. Other factors that can affect the severity of thalassemia include the type and location of the genetic mutation, as well as the presence of additional genetic or environmental factors that can affect the production of hemoglobin.
Genetics
Prognostic Factors
The prognosis of thalassemia can vary depending on the type and severity of the condition. Individuals with milder forms of thalassemia may have a normal lifespan, while those with more severe forms may have a shortened lifespan and experience significant health complications. In general, early diagnosis and appropriate management can improve outcomes and quality of life for individuals with thalassemia.
Regular blood transfusions and iron chelation therapy can help prevent or minimize complications associated with anemia and iron overload, such as organ damage and infection. Bone marrow transplants have the potential to cure the condition, but they are associated with significant risks and are not appropriate for all individuals.
Overall, the prognosis for thalassemia has improved significantly in recent years with advancements in medical management and supportive care. It’s important for individuals with thalassemia to work closely with their healthcare provider to manage their condition and optimize their long-term outcomes.
Clinical History
Clinical presentation
The clinical presentation of thalassemia can vary widely depending on the type and severity of the condition. Some common signs and symptoms of thalassemia include:
Anemia: Thalassemia can cause a reduction in the number of red blood cells, leading to anemia. Symptoms of anemia may include fatigue, weakness, pale skin, and shortness of breath.
Enlarged spleen: Thalassemia can cause the spleen to enlarge as it works to remove damaged red blood cells from circulation. This can cause abdominal swelling or discomfort.
Jaundice: In severe cases, thalassemia can cause jaundice, a yellowing of the skin and eyes, due to the buildup of bilirubin, a waste product produced by the liver.
Delayed growth and development: Children with severe thalassemia may experience delayed growth and development due to a lack of oxygen-carrying red blood cells.
Bone deformities: Thalassemia can cause bone deformities, particularly in the face and skull, due to the overgrowth of bone marrow.
Heart problems: People with severe thalassemia may be at risk for heart problems, such as heart failure or arrhythmias, due to the strain on the heart caused by the condition.
It’s worth noting that carriers of thalassemia typically do not experience any symptoms, as they still produce enough healthy red blood cells to function normally. The severity of thalassemia can vary widely, even among people with the same genetic mutation, so it’s important for individuals with a family history of thalassemia to undergo genetic testing to determine their risk.
Physical Examination
Physical examination
During a physical examination, a healthcare provider may look for signs and symptoms that could indicate thalassemia, such as:
Pale skin: Thalassemia can cause a reduction in the number of red blood cells, which can lead to pale or yellowish skin.
Enlarged spleen: Thalassemia can cause the spleen to enlarge as it works to remove damaged red blood cells from circulation.
Abdominal swelling: An enlarged spleen can cause swelling or discomfort in the abdomen.
Jaundice: In severe cases, thalassemia can cause jaundice, a yellowing of the skin and eyes, due to the buildup of bilirubin, a waste product produced by the liver.
Fatigue: Thalassemia can cause fatigue and weakness due to a lack of oxygen-carrying red blood cells.
Shortness of breath: If the anemia is severe, it can cause shortness of breath and other respiratory symptoms.
In addition to a physical examination, a healthcare provider may order blood tests to check for abnormalities in red blood cell counts, hemoglobin levels, and other markers of thalassemia. They may also conduct genetic testing to confirm the diagnosis and determine the type and severity of thalassemia.
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Differential diagnosis
Thalassemia can be difficult to diagnose based on symptoms alone, as the signs and symptoms can be similar to other conditions.
A differential diagnosis for thalassemia may include the following:
Iron-deficiency anemia: This is the most common form of anemia, and it occurs when the body does not have enough iron to produce hemoglobin. Iron-deficiency anemia can cause fatigue, weakness, and pale skin, which are similar to symptoms of thalassemia.
Sickle cell anemia: This is another genetic disorder that affects hemoglobin, but it is caused by a different type of mutation. Symptoms of sickle cell anemia can include pain, fatigue, and frequent infections, which can also occur in thalassemia.
Hemoglobin E trait: This is a genetic trait that can cause mild anemia and is common in Southeast Asia. People with hemoglobin E trait may have symptoms similar to thalassemia, but the severity of the anemia is typically less severe.
Alpha-1 antitrypsin deficiency: This is a genetic disorder that can cause liver and lung disease, but it can also cause anemia. Symptoms of alpha-1 antitrypsin deficiency can include fatigue, shortness of breath, and pale skin, which are similar to symptoms of thalassemia.
Lead poisoning: Exposure to high levels of lead can cause anemia and other symptoms, including fatigue, irritability, and abdominal pain, which can be similar to symptoms of thalassemia.
Other types of hemoglobinopathies: There are other genetic disorders that can affect the production of hemoglobin, including Hb H disease and Hb Lepore. These disorders can cause symptoms similar to thalassemia.
If a person is suspected to have thalassemia, a blood test can be done to confirm the diagnosis and determine the severity of the condition.
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
The management of thalassemia can involve a combination of treatments depending on the severity of the condition.
Here are some common management strategies:
Blood transfusions: Regular blood transfusions can be given to individuals with severe thalassemia to replace the deficient red blood cells. The frequency of transfusions varies depending on the severity of the condition.
Iron chelation therapy: Blood transfusions can lead to an excess buildup of iron in the body, which can be toxic. Iron chelation therapy involves the use of medications to remove excess iron from the body.
Folic acid supplementation: Individuals with thalassemia may have a higher need for folic acid, which is important for the production of healthy red blood cells.
Bone marrow transplant: In severe cases of thalassemia, a bone marrow transplant may be considered as a potential cure. This involves replacing the patient’s bone marrow with healthy donor bone marrow.
Supportive care: Other supportive measures, such as pain management and physical therapy, may be necessary to address any associated symptoms or complications.
It’s important for individuals with thalassemia to work closely with their healthcare provider to develop an individualized treatment plan. In addition, genetic counseling may be recommended for individuals with a family history of thalassemia to discuss their risk and options for prenatal testing.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Future Trends
Media Gallary
References
https://www.ncbi.nlm.nih.gov/books/NBK531481/
News
Female Surgeons in NHS Face Rampant Sexual Harassment
Posted on
News
Gene Therapy Promises Restoration of Motor Function
Posted on
News
Ultra-Processed Foods Linked to Elevated Depression Risk in Women
Posted on
News
Research Reveals How Language Shapes Social Memory in the Brain
Thalassemia is a genetic disorder that affects the production of hemoglobin, a protein found in red blood cells that carries oxygen throughout the body. It is caused by mutations in the genes that control the production of hemoglobin, which leads to the production of abnormal hemoglobin molecules or a decrease in the amount of hemoglobin produced.
There are two main types of thalassemia: alpha thalassemia and beta thalassemia. Alpha thalassemia occurs when there is a defect in the genes that produce alpha globin chains, while beta thalassemia occurs when there is a defect in the genes that produce beta globin chains.
Thalassemia is a global health problem, with an estimated 300,000 to 500,000 babies born with the disorder each year worldwide. The prevalence of thalassemia varies widely depending on the region and ethnic group. The disorder is most common in populations from the Mediterranean, Middle East, South Asia, and Southeast Asia, where it is estimated that up to 8% of the population may carry the genetic mutation for thalassemia.
In these regions, thalassemia is often referred to as a “silent epidemic.” In the United States, thalassemia is relatively rare, with an estimated 1,000 cases diagnosed each year. It is most commonly found in people of Italian, Greek, Middle Eastern, and Asian descent. Thalassemia is more prevalent in areas where malaria is endemic, as carriers of the thalassemia gene are less likely to develop severe forms of the disease.
As a result, the highest rates of thalassemia occur in areas where malaria is prevalent, such as in sub-Saharan Africa, Southeast Asia, and parts of the Middle East. Overall, thalassemia is a significant public health issue with a substantial impact on affected individuals and their families. It is important for healthcare providers to be aware of the prevalence of thalassemia in their patient populations and to provide appropriate screening and management of the disorder.
There are two types of thalassemia: alpha thalassemia and beta thalassemia. Alpha thalassemia occurs when there is a mutation in one or more of the four genes that control the production of alpha globin chains. Beta thalassemia occurs when there is a mutation in one or both of the two genes that control the production of beta-globin chains.
In most cases, thalassemia is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. People who inherit only one copy of the mutated gene are carriers of the disorder and typically do not experience any symptoms.
There are also rare cases of thalassemia that are caused by spontaneous mutations in the genes responsible for the production of hemoglobin. These cases are not inherited and occur randomly in individuals with no family history of the disorder. Other factors that can affect the severity of thalassemia include the type and location of the genetic mutation, as well as the presence of additional genetic or environmental factors that can affect the production of hemoglobin.
The prognosis of thalassemia can vary depending on the type and severity of the condition. Individuals with milder forms of thalassemia may have a normal lifespan, while those with more severe forms may have a shortened lifespan and experience significant health complications. In general, early diagnosis and appropriate management can improve outcomes and quality of life for individuals with thalassemia.
Regular blood transfusions and iron chelation therapy can help prevent or minimize complications associated with anemia and iron overload, such as organ damage and infection. Bone marrow transplants have the potential to cure the condition, but they are associated with significant risks and are not appropriate for all individuals.
Overall, the prognosis for thalassemia has improved significantly in recent years with advancements in medical management and supportive care. It’s important for individuals with thalassemia to work closely with their healthcare provider to manage their condition and optimize their long-term outcomes.
Clinical presentation
The clinical presentation of thalassemia can vary widely depending on the type and severity of the condition. Some common signs and symptoms of thalassemia include:
Anemia: Thalassemia can cause a reduction in the number of red blood cells, leading to anemia. Symptoms of anemia may include fatigue, weakness, pale skin, and shortness of breath.
Enlarged spleen: Thalassemia can cause the spleen to enlarge as it works to remove damaged red blood cells from circulation. This can cause abdominal swelling or discomfort.
Jaundice: In severe cases, thalassemia can cause jaundice, a yellowing of the skin and eyes, due to the buildup of bilirubin, a waste product produced by the liver.
Delayed growth and development: Children with severe thalassemia may experience delayed growth and development due to a lack of oxygen-carrying red blood cells.
Bone deformities: Thalassemia can cause bone deformities, particularly in the face and skull, due to the overgrowth of bone marrow.
Heart problems: People with severe thalassemia may be at risk for heart problems, such as heart failure or arrhythmias, due to the strain on the heart caused by the condition.
It’s worth noting that carriers of thalassemia typically do not experience any symptoms, as they still produce enough healthy red blood cells to function normally. The severity of thalassemia can vary widely, even among people with the same genetic mutation, so it’s important for individuals with a family history of thalassemia to undergo genetic testing to determine their risk.
Physical examination
During a physical examination, a healthcare provider may look for signs and symptoms that could indicate thalassemia, such as:
Pale skin: Thalassemia can cause a reduction in the number of red blood cells, which can lead to pale or yellowish skin.
Enlarged spleen: Thalassemia can cause the spleen to enlarge as it works to remove damaged red blood cells from circulation.
Abdominal swelling: An enlarged spleen can cause swelling or discomfort in the abdomen.
Jaundice: In severe cases, thalassemia can cause jaundice, a yellowing of the skin and eyes, due to the buildup of bilirubin, a waste product produced by the liver.
Fatigue: Thalassemia can cause fatigue and weakness due to a lack of oxygen-carrying red blood cells.
Shortness of breath: If the anemia is severe, it can cause shortness of breath and other respiratory symptoms.
In addition to a physical examination, a healthcare provider may order blood tests to check for abnormalities in red blood cell counts, hemoglobin levels, and other markers of thalassemia. They may also conduct genetic testing to confirm the diagnosis and determine the type and severity of thalassemia.
Differential diagnosis
Thalassemia can be difficult to diagnose based on symptoms alone, as the signs and symptoms can be similar to other conditions.
A differential diagnosis for thalassemia may include the following:
Iron-deficiency anemia: This is the most common form of anemia, and it occurs when the body does not have enough iron to produce hemoglobin. Iron-deficiency anemia can cause fatigue, weakness, and pale skin, which are similar to symptoms of thalassemia.
Sickle cell anemia: This is another genetic disorder that affects hemoglobin, but it is caused by a different type of mutation. Symptoms of sickle cell anemia can include pain, fatigue, and frequent infections, which can also occur in thalassemia.
Hemoglobin E trait: This is a genetic trait that can cause mild anemia and is common in Southeast Asia. People with hemoglobin E trait may have symptoms similar to thalassemia, but the severity of the anemia is typically less severe.
Alpha-1 antitrypsin deficiency: This is a genetic disorder that can cause liver and lung disease, but it can also cause anemia. Symptoms of alpha-1 antitrypsin deficiency can include fatigue, shortness of breath, and pale skin, which are similar to symptoms of thalassemia.
Lead poisoning: Exposure to high levels of lead can cause anemia and other symptoms, including fatigue, irritability, and abdominal pain, which can be similar to symptoms of thalassemia.
Other types of hemoglobinopathies: There are other genetic disorders that can affect the production of hemoglobin, including Hb H disease and Hb Lepore. These disorders can cause symptoms similar to thalassemia.
If a person is suspected to have thalassemia, a blood test can be done to confirm the diagnosis and determine the severity of the condition.
The management of thalassemia can involve a combination of treatments depending on the severity of the condition.
Here are some common management strategies:
Blood transfusions: Regular blood transfusions can be given to individuals with severe thalassemia to replace the deficient red blood cells. The frequency of transfusions varies depending on the severity of the condition.
Iron chelation therapy: Blood transfusions can lead to an excess buildup of iron in the body, which can be toxic. Iron chelation therapy involves the use of medications to remove excess iron from the body.
Folic acid supplementation: Individuals with thalassemia may have a higher need for folic acid, which is important for the production of healthy red blood cells.
Bone marrow transplant: In severe cases of thalassemia, a bone marrow transplant may be considered as a potential cure. This involves replacing the patient’s bone marrow with healthy donor bone marrow.
Supportive care: Other supportive measures, such as pain management and physical therapy, may be necessary to address any associated symptoms or complications.
It’s important for individuals with thalassemia to work closely with their healthcare provider to develop an individualized treatment plan. In addition, genetic counseling may be recommended for individuals with a family history of thalassemia to discuss their risk and options for prenatal testing.
https://www.ncbi.nlm.nih.gov/books/NBK531481/
medtigo
Thalassemia
Updated :
August 30, 2023
Thalassemia is a genetic disorder that affects the production of hemoglobin, a protein found in red blood cells that carries oxygen throughout the body. It is caused by mutations in the genes that control the production of hemoglobin, which leads to the production of abnormal hemoglobin molecules or a decrease in the amount of hemoglobin produced.
There are two main types of thalassemia: alpha thalassemia and beta thalassemia. Alpha thalassemia occurs when there is a defect in the genes that produce alpha globin chains, while beta thalassemia occurs when there is a defect in the genes that produce beta globin chains.
Thalassemia is a global health problem, with an estimated 300,000 to 500,000 babies born with the disorder each year worldwide. The prevalence of thalassemia varies widely depending on the region and ethnic group. The disorder is most common in populations from the Mediterranean, Middle East, South Asia, and Southeast Asia, where it is estimated that up to 8% of the population may carry the genetic mutation for thalassemia.
In these regions, thalassemia is often referred to as a “silent epidemic.” In the United States, thalassemia is relatively rare, with an estimated 1,000 cases diagnosed each year. It is most commonly found in people of Italian, Greek, Middle Eastern, and Asian descent. Thalassemia is more prevalent in areas where malaria is endemic, as carriers of the thalassemia gene are less likely to develop severe forms of the disease.
As a result, the highest rates of thalassemia occur in areas where malaria is prevalent, such as in sub-Saharan Africa, Southeast Asia, and parts of the Middle East. Overall, thalassemia is a significant public health issue with a substantial impact on affected individuals and their families. It is important for healthcare providers to be aware of the prevalence of thalassemia in their patient populations and to provide appropriate screening and management of the disorder.
There are two types of thalassemia: alpha thalassemia and beta thalassemia. Alpha thalassemia occurs when there is a mutation in one or more of the four genes that control the production of alpha globin chains. Beta thalassemia occurs when there is a mutation in one or both of the two genes that control the production of beta-globin chains.
In most cases, thalassemia is inherited in an autosomal recessive pattern, which means that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the disorder. People who inherit only one copy of the mutated gene are carriers of the disorder and typically do not experience any symptoms.
There are also rare cases of thalassemia that are caused by spontaneous mutations in the genes responsible for the production of hemoglobin. These cases are not inherited and occur randomly in individuals with no family history of the disorder. Other factors that can affect the severity of thalassemia include the type and location of the genetic mutation, as well as the presence of additional genetic or environmental factors that can affect the production of hemoglobin.
The prognosis of thalassemia can vary depending on the type and severity of the condition. Individuals with milder forms of thalassemia may have a normal lifespan, while those with more severe forms may have a shortened lifespan and experience significant health complications. In general, early diagnosis and appropriate management can improve outcomes and quality of life for individuals with thalassemia.
Regular blood transfusions and iron chelation therapy can help prevent or minimize complications associated with anemia and iron overload, such as organ damage and infection. Bone marrow transplants have the potential to cure the condition, but they are associated with significant risks and are not appropriate for all individuals.
Overall, the prognosis for thalassemia has improved significantly in recent years with advancements in medical management and supportive care. It’s important for individuals with thalassemia to work closely with their healthcare provider to manage their condition and optimize their long-term outcomes.
Clinical presentation
The clinical presentation of thalassemia can vary widely depending on the type and severity of the condition. Some common signs and symptoms of thalassemia include:
Anemia: Thalassemia can cause a reduction in the number of red blood cells, leading to anemia. Symptoms of anemia may include fatigue, weakness, pale skin, and shortness of breath.
Enlarged spleen: Thalassemia can cause the spleen to enlarge as it works to remove damaged red blood cells from circulation. This can cause abdominal swelling or discomfort.
Jaundice: In severe cases, thalassemia can cause jaundice, a yellowing of the skin and eyes, due to the buildup of bilirubin, a waste product produced by the liver.
Delayed growth and development: Children with severe thalassemia may experience delayed growth and development due to a lack of oxygen-carrying red blood cells.
Bone deformities: Thalassemia can cause bone deformities, particularly in the face and skull, due to the overgrowth of bone marrow.
Heart problems: People with severe thalassemia may be at risk for heart problems, such as heart failure or arrhythmias, due to the strain on the heart caused by the condition.
It’s worth noting that carriers of thalassemia typically do not experience any symptoms, as they still produce enough healthy red blood cells to function normally. The severity of thalassemia can vary widely, even among people with the same genetic mutation, so it’s important for individuals with a family history of thalassemia to undergo genetic testing to determine their risk.
Physical examination
During a physical examination, a healthcare provider may look for signs and symptoms that could indicate thalassemia, such as:
Pale skin: Thalassemia can cause a reduction in the number of red blood cells, which can lead to pale or yellowish skin.
Enlarged spleen: Thalassemia can cause the spleen to enlarge as it works to remove damaged red blood cells from circulation.
Abdominal swelling: An enlarged spleen can cause swelling or discomfort in the abdomen.
Jaundice: In severe cases, thalassemia can cause jaundice, a yellowing of the skin and eyes, due to the buildup of bilirubin, a waste product produced by the liver.
Fatigue: Thalassemia can cause fatigue and weakness due to a lack of oxygen-carrying red blood cells.
Shortness of breath: If the anemia is severe, it can cause shortness of breath and other respiratory symptoms.
In addition to a physical examination, a healthcare provider may order blood tests to check for abnormalities in red blood cell counts, hemoglobin levels, and other markers of thalassemia. They may also conduct genetic testing to confirm the diagnosis and determine the type and severity of thalassemia.
Differential diagnosis
Thalassemia can be difficult to diagnose based on symptoms alone, as the signs and symptoms can be similar to other conditions.
A differential diagnosis for thalassemia may include the following:
Iron-deficiency anemia: This is the most common form of anemia, and it occurs when the body does not have enough iron to produce hemoglobin. Iron-deficiency anemia can cause fatigue, weakness, and pale skin, which are similar to symptoms of thalassemia.
Sickle cell anemia: This is another genetic disorder that affects hemoglobin, but it is caused by a different type of mutation. Symptoms of sickle cell anemia can include pain, fatigue, and frequent infections, which can also occur in thalassemia.
Hemoglobin E trait: This is a genetic trait that can cause mild anemia and is common in Southeast Asia. People with hemoglobin E trait may have symptoms similar to thalassemia, but the severity of the anemia is typically less severe.
Alpha-1 antitrypsin deficiency: This is a genetic disorder that can cause liver and lung disease, but it can also cause anemia. Symptoms of alpha-1 antitrypsin deficiency can include fatigue, shortness of breath, and pale skin, which are similar to symptoms of thalassemia.
Lead poisoning: Exposure to high levels of lead can cause anemia and other symptoms, including fatigue, irritability, and abdominal pain, which can be similar to symptoms of thalassemia.
Other types of hemoglobinopathies: There are other genetic disorders that can affect the production of hemoglobin, including Hb H disease and Hb Lepore. These disorders can cause symptoms similar to thalassemia.
If a person is suspected to have thalassemia, a blood test can be done to confirm the diagnosis and determine the severity of the condition.
The management of thalassemia can involve a combination of treatments depending on the severity of the condition.
Here are some common management strategies:
Blood transfusions: Regular blood transfusions can be given to individuals with severe thalassemia to replace the deficient red blood cells. The frequency of transfusions varies depending on the severity of the condition.
Iron chelation therapy: Blood transfusions can lead to an excess buildup of iron in the body, which can be toxic. Iron chelation therapy involves the use of medications to remove excess iron from the body.
Folic acid supplementation: Individuals with thalassemia may have a higher need for folic acid, which is important for the production of healthy red blood cells.
Bone marrow transplant: In severe cases of thalassemia, a bone marrow transplant may be considered as a potential cure. This involves replacing the patient’s bone marrow with healthy donor bone marrow.
Supportive care: Other supportive measures, such as pain management and physical therapy, may be necessary to address any associated symptoms or complications.
It’s important for individuals with thalassemia to work closely with their healthcare provider to develop an individualized treatment plan. In addition, genetic counseling may be recommended for individuals with a family history of thalassemia to discuss their risk and options for prenatal testing.
https://www.ncbi.nlm.nih.gov/books/NBK531481/
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
